Patient Derived Xenograft (PDX) Mouse Models and Efficacy Services
Patient-derived tumor xenograft (PDX) models have attracted increasing attention in recent years as a preclinical animal model for cancer research. By transplanting fresh tumor tissue from patients into immunodeficient mice, PDX models can preserve the heterogeneity and complexity of the original tumors and more accurately reflect the biological characteristics, pathological classification, molecular marker expression, gene mutation types, and other features of patient tumors. Compared with traditional cell line-derived xenograft models, PDX models have shown great potential in drug screening, drug development, and personalized medicine due to their ability to recapitulate the patient's tumor microenvironment and predict treatment response. Discover a world of possibilities with GemPharmatech's diverse range of PDX models. Our innovative PDX models, developed with cutting-edge technology, offer unparalleled accuracy and are trusted by leading pharmaceutical institutions worldwide.